Body mass index and survival after diagnosis of invasive breast cancer

a study based on the Japanese National Clinical Database—Breast Cancer Registry

Masaaki Kawai, Ai Tomotaki, Hiroaki Miyata, Takayuki Iwamoto, Naoki Niikura, Keisei Anan, Naoki Hayashi, Kenjiro Aogi, Takanori Ishida, Hideji Masuoka, Kotaro Iijima, Shinobu Masuda, Koichiro Tsugawa, Takayuki Kinoshita, Seigo Nakamura, Yutaka Tokuda

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Few studies have reported the association between body mass index (BMI) and outcome among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast cancer patients who had been followed-up for a median period of 6.7 years entered in the National Clinical Database–Breast Cancer Registry between 2004 and 2006. We used mainly the WHO criteria for BMI (kg/m2) categories; <18.5 (underweight), ≥18.5–<21.8 (reference), ≥21.8–<25, ≥25–<30 (overweight), and ≥30 (obese). We divided normal weight patients into two subgroups because this category includes many patients compared to others. The timing of BMI measurement was not specified. The Cox proportional hazards model and cubic spline regression were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking, alcohol, and physical activity were not controlled. A total of 1418 all-cause, 937 breast cancer–specific deaths, and 2433 recurrences were observed. Obesity was associated with an increased risk of all-cause (HR: 1.46; 95% CI: 1.16–1.83) and breast cancer–specific death (HR: 1.47; 95% CI: 1.11–1.93) for all patients, and with all-cause (HR: 1.47; 95% CI: 1.13–1.92) and breast cancer–specific death (HR: 1.58; 95% CI: 1.13–2.20) for postmenopausal patients. Being underweight was associated with an increased risk of all-cause death for all (HR: 1.41; 95% CI: 1.16–1.71) and for postmenopausal patients (HR: 1.45; 95% CI: 1.15–1.84). With regard to subtype and menopausal status, obesity was associated with an increased risk of breast cancer–specific death for all cases of luminal B tumor (HR: 2.59; 95% CI: 1.51–4.43; Pheterogeneity of Luminal B vs. Triple negative = 0.016) and for postmenopausal patients with luminal B tumor (HR: 3.24; 95% CI: 1.71–6.17). Being obese or underweight is associated with a higher risk of death among female breast cancer patients in Japan.

Original languageEnglish
Pages (from-to)1328-1340
Number of pages13
JournalCancer Medicine
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Registries
Body Mass Index
Confidence Intervals
Breast Neoplasms
Survival
Neoplasms
Thinness
Breast
Obesity
Proportional Hazards Models
Cause of Death
Japan
Smoking
Alcohols
Exercise
Weights and Measures
Recurrence

Keywords

  • Body mass index
  • breast cancer
  • menopausal status
  • subtypes
  • survival

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Body mass index and survival after diagnosis of invasive breast cancer : a study based on the Japanese National Clinical Database—Breast Cancer Registry. / Kawai, Masaaki; Tomotaki, Ai; Miyata, Hiroaki; Iwamoto, Takayuki; Niikura, Naoki; Anan, Keisei; Hayashi, Naoki; Aogi, Kenjiro; Ishida, Takanori; Masuoka, Hideji; Iijima, Kotaro; Masuda, Shinobu; Tsugawa, Koichiro; Kinoshita, Takayuki; Nakamura, Seigo; Tokuda, Yutaka.

In: Cancer Medicine, Vol. 5, No. 6, 01.06.2016, p. 1328-1340.

Research output: Contribution to journalArticle

Kawai, M, Tomotaki, A, Miyata, H, Iwamoto, T, Niikura, N, Anan, K, Hayashi, N, Aogi, K, Ishida, T, Masuoka, H, Iijima, K, Masuda, S, Tsugawa, K, Kinoshita, T, Nakamura, S & Tokuda, Y 2016, 'Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry', Cancer Medicine, vol. 5, no. 6, pp. 1328-1340. https://doi.org/10.1002/cam4.678
Kawai, Masaaki ; Tomotaki, Ai ; Miyata, Hiroaki ; Iwamoto, Takayuki ; Niikura, Naoki ; Anan, Keisei ; Hayashi, Naoki ; Aogi, Kenjiro ; Ishida, Takanori ; Masuoka, Hideji ; Iijima, Kotaro ; Masuda, Shinobu ; Tsugawa, Koichiro ; Kinoshita, Takayuki ; Nakamura, Seigo ; Tokuda, Yutaka. / Body mass index and survival after diagnosis of invasive breast cancer : a study based on the Japanese National Clinical Database—Breast Cancer Registry. In: Cancer Medicine. 2016 ; Vol. 5, No. 6. pp. 1328-1340.
@article{d2ce317f90844daabe2d3f3a3c40e8f7,
title = "Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry",
abstract = "Few studies have reported the association between body mass index (BMI) and outcome among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast cancer patients who had been followed-up for a median period of 6.7 years entered in the National Clinical Database–Breast Cancer Registry between 2004 and 2006. We used mainly the WHO criteria for BMI (kg/m2) categories; <18.5 (underweight), ≥18.5–<21.8 (reference), ≥21.8–<25, ≥25–<30 (overweight), and ≥30 (obese). We divided normal weight patients into two subgroups because this category includes many patients compared to others. The timing of BMI measurement was not specified. The Cox proportional hazards model and cubic spline regression were used to estimate hazard ratios (HRs) and 95{\%} confidence intervals (CIs). Smoking, alcohol, and physical activity were not controlled. A total of 1418 all-cause, 937 breast cancer–specific deaths, and 2433 recurrences were observed. Obesity was associated with an increased risk of all-cause (HR: 1.46; 95{\%} CI: 1.16–1.83) and breast cancer–specific death (HR: 1.47; 95{\%} CI: 1.11–1.93) for all patients, and with all-cause (HR: 1.47; 95{\%} CI: 1.13–1.92) and breast cancer–specific death (HR: 1.58; 95{\%} CI: 1.13–2.20) for postmenopausal patients. Being underweight was associated with an increased risk of all-cause death for all (HR: 1.41; 95{\%} CI: 1.16–1.71) and for postmenopausal patients (HR: 1.45; 95{\%} CI: 1.15–1.84). With regard to subtype and menopausal status, obesity was associated with an increased risk of breast cancer–specific death for all cases of luminal B tumor (HR: 2.59; 95{\%} CI: 1.51–4.43; Pheterogeneity of Luminal B vs. Triple negative = 0.016) and for postmenopausal patients with luminal B tumor (HR: 3.24; 95{\%} CI: 1.71–6.17). Being obese or underweight is associated with a higher risk of death among female breast cancer patients in Japan.",
keywords = "Body mass index, breast cancer, menopausal status, subtypes, survival",
author = "Masaaki Kawai and Ai Tomotaki and Hiroaki Miyata and Takayuki Iwamoto and Naoki Niikura and Keisei Anan and Naoki Hayashi and Kenjiro Aogi and Takanori Ishida and Hideji Masuoka and Kotaro Iijima and Shinobu Masuda and Koichiro Tsugawa and Takayuki Kinoshita and Seigo Nakamura and Yutaka Tokuda",
year = "2016",
month = "6",
day = "1",
doi = "10.1002/cam4.678",
language = "English",
volume = "5",
pages = "1328--1340",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Body mass index and survival after diagnosis of invasive breast cancer

T2 - a study based on the Japanese National Clinical Database—Breast Cancer Registry

AU - Kawai, Masaaki

AU - Tomotaki, Ai

AU - Miyata, Hiroaki

AU - Iwamoto, Takayuki

AU - Niikura, Naoki

AU - Anan, Keisei

AU - Hayashi, Naoki

AU - Aogi, Kenjiro

AU - Ishida, Takanori

AU - Masuoka, Hideji

AU - Iijima, Kotaro

AU - Masuda, Shinobu

AU - Tsugawa, Koichiro

AU - Kinoshita, Takayuki

AU - Nakamura, Seigo

AU - Tokuda, Yutaka

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Few studies have reported the association between body mass index (BMI) and outcome among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast cancer patients who had been followed-up for a median period of 6.7 years entered in the National Clinical Database–Breast Cancer Registry between 2004 and 2006. We used mainly the WHO criteria for BMI (kg/m2) categories; <18.5 (underweight), ≥18.5–<21.8 (reference), ≥21.8–<25, ≥25–<30 (overweight), and ≥30 (obese). We divided normal weight patients into two subgroups because this category includes many patients compared to others. The timing of BMI measurement was not specified. The Cox proportional hazards model and cubic spline regression were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking, alcohol, and physical activity were not controlled. A total of 1418 all-cause, 937 breast cancer–specific deaths, and 2433 recurrences were observed. Obesity was associated with an increased risk of all-cause (HR: 1.46; 95% CI: 1.16–1.83) and breast cancer–specific death (HR: 1.47; 95% CI: 1.11–1.93) for all patients, and with all-cause (HR: 1.47; 95% CI: 1.13–1.92) and breast cancer–specific death (HR: 1.58; 95% CI: 1.13–2.20) for postmenopausal patients. Being underweight was associated with an increased risk of all-cause death for all (HR: 1.41; 95% CI: 1.16–1.71) and for postmenopausal patients (HR: 1.45; 95% CI: 1.15–1.84). With regard to subtype and menopausal status, obesity was associated with an increased risk of breast cancer–specific death for all cases of luminal B tumor (HR: 2.59; 95% CI: 1.51–4.43; Pheterogeneity of Luminal B vs. Triple negative = 0.016) and for postmenopausal patients with luminal B tumor (HR: 3.24; 95% CI: 1.71–6.17). Being obese or underweight is associated with a higher risk of death among female breast cancer patients in Japan.

AB - Few studies have reported the association between body mass index (BMI) and outcome among Asian breast cancer patients. We analyzed data for 20,090 female invasive breast cancer patients who had been followed-up for a median period of 6.7 years entered in the National Clinical Database–Breast Cancer Registry between 2004 and 2006. We used mainly the WHO criteria for BMI (kg/m2) categories; <18.5 (underweight), ≥18.5–<21.8 (reference), ≥21.8–<25, ≥25–<30 (overweight), and ≥30 (obese). We divided normal weight patients into two subgroups because this category includes many patients compared to others. The timing of BMI measurement was not specified. The Cox proportional hazards model and cubic spline regression were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking, alcohol, and physical activity were not controlled. A total of 1418 all-cause, 937 breast cancer–specific deaths, and 2433 recurrences were observed. Obesity was associated with an increased risk of all-cause (HR: 1.46; 95% CI: 1.16–1.83) and breast cancer–specific death (HR: 1.47; 95% CI: 1.11–1.93) for all patients, and with all-cause (HR: 1.47; 95% CI: 1.13–1.92) and breast cancer–specific death (HR: 1.58; 95% CI: 1.13–2.20) for postmenopausal patients. Being underweight was associated with an increased risk of all-cause death for all (HR: 1.41; 95% CI: 1.16–1.71) and for postmenopausal patients (HR: 1.45; 95% CI: 1.15–1.84). With regard to subtype and menopausal status, obesity was associated with an increased risk of breast cancer–specific death for all cases of luminal B tumor (HR: 2.59; 95% CI: 1.51–4.43; Pheterogeneity of Luminal B vs. Triple negative = 0.016) and for postmenopausal patients with luminal B tumor (HR: 3.24; 95% CI: 1.71–6.17). Being obese or underweight is associated with a higher risk of death among female breast cancer patients in Japan.

KW - Body mass index

KW - breast cancer

KW - menopausal status

KW - subtypes

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84991522702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991522702&partnerID=8YFLogxK

U2 - 10.1002/cam4.678

DO - 10.1002/cam4.678

M3 - Article

VL - 5

SP - 1328

EP - 1340

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 6

ER -